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Abstract
The T3SS injectisome is a syringe-shaped macromolecular assembly found in pathogenic Gram-negative bacteria that allows
for the direct delivery of virulence effectors into host cells. It is composed of a ‘‘basal body’’, a lock-nut structure spanning
both bacterial membranes, and a ‘‘needle’’ that protrudes away from the bacterial surface. A hollow channel spans
throughout the apparatus, permitting the translocation of effector proteins from the bacterial cytosol to the host plasma
membrane. The basal body is composed largely of three membrane-embedded proteins that form oligomerized concentric
rings. Here, we report the crystal structures of three domains of the prototypical Salmonella SPI-1 basal body, and use a new
approach incorporating symmetric flexible backbone docking and EM data to produce a model for their oligomeric
assembly. The obtained models, validated by biochemical and in vivo assays, reveal the molecular details of the interactions
driving basal body assembly, and notably demonstrate a conserved oligomerization mechanism.
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Introduction
The bacterial injectisome, or type III secretion system (T3SS), is
a specialized syringe-shaped protein-export system utilized by
many pathogenic Gram-negative bacteria for the injection of
virulence proteins (effectors) into host cells. Bacterial proteins
destined for both needle assembly and host cell targeting are
translocated via the injectisome in a process known as type III
secretion [1]. The injectisome can be divided into three major
regions: the inner- (IM) and outer-membrane (OM) spanning basal
body with associated export apparatus and ATPase components,
an extracellular needle, and a terminating pore inserted into the
host cell membrane called the translocon (for review see ref [2,3]).
The major structural scaffold of the basal body is comprised
largely of three proteins that arrange into a series of highly
oligomerized, concentric rings: two intimately associated proteins
localized to the IM - PrgK/EscJ/MxiJ and PrgH/EscD/MxiG,
and a third protein belonging to the secretin family of OM
proteins, InvG/EscC/MxiD (Salmonella enterica serovar Typhimur-
ium SPI-1, Enteropathogenic Escherichia coli (EPEC) LEE and
Shigella dysenteriae nomenclature, respectively) (Figure 1A)
[4,5,6,7,8].
S. Typhimurium is an important medical pathogen causing
gastroenteritis in infected individuals. Two of the major virulence
determining factors are the discrete T3SSs encoded by the
Salmonella Pathogenicity Islands (SPI) 1 and 2, which are required
for bacterial invasion and replication within host cells [9]. The
SPI-1 system, belonging to the mxi-spa evolutionary family which
also includes the Shigella dysenteriae T3SS [10], is considered the
prototypical T3SS and has been the focus of structural charac-
terization using a variety of techniques including the first cryo-
electron microscopy (EM) 3D reconstruction of a T3SS needle
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complex [7] revealing its supramolecular assembly. More recently,
a cryo-EM analysis of the SPI-1 injectisome at ,10 A˚ resolution
has provided unprecedented detail of the overall architecture of
the basal body [11]. We have previously published the x-ray
crystallographically determined structures of the periplasmic
domain of the S. Typhimurium basal body protein PrgH, in
addition to the periplasmic domains of EPEC PrgK homologue
EscJ and InvG homologue EscC [6,12]. These structures defined a
common modular domain (ring-building motif; RBM) hypothe-
sized to be involved in ring oligomerization and have been used,
along with the available EM data, in all subsequent studies
modelling the assembly of these basal body components. The
accuracy of these preliminary molecular models [11,12,13],
however, has been hampered by the use of tentative homology
models for some domains, and the lack of structural information
entirely for others.
Results
Here, we make new advances in compiling the precise
molecular details of the Salmonella SPI-1 injectisome. Specifically,
we report the crystal structures of the cytoplasmic domain of the
IM ring protein PrgH11–120 (and a new crystal form of its
periplasmic domain PrgH170–392 with improved resolution and
detail), as well as the structure of the periplasmic domain of the
OM ring InvG. (Figure 1B, Table 1). Collectively these structures
provide the most cohesive set of T3SS basal body atomic-
resolution structures known from a single species.
Using these structures, we have modelled the symmetric ring
assemblies by flexible backbone symmetric docking guided by the
above EM data (the higher-resolution map EMD-1875 was used
unless specified), with the generalized symmetric modelling
framework in the program Rosetta [14] (Figures 2 and S1; See
Materials and Methods and Appendix S1 for details). This
framework makes conformational sampling in symmetric systems
tractable by 1) only considering conformations that are consistent
with the symmetry of the system and 2) performing a minimal
number of energy and derivative evaluations by explicitly
simulating only a subset of the interacting monomers and
propagating conformational changes to symmetry-related sub-
units. We implemented a two-step approach to explore symmetric
ring conformations consistent with EM data: First, we used an
initial global fixed-backbone search starting from a randomized
orientation of the monomeric subunits incorporating a score term
measuring correlation to the EM data [15,16] (Figure 2A); this step
aims to globally identify ring arrangements that are consistent with
the EM data. The candidate fixed-backbone conformations
identified in the first step are then explored locally in more detail
using symmetric, all-atom refinement with full backbone flexibility
[17] (Figure 2B). This step aims at optimizing the symmetric
arrangements identified previously by capturing any (small)
changes in the backbone conformation. To retain consistency to
the EM data, an EM score term with reduced bias is used in the
second step. Conformations with the lowest combined score (full
atom energy and EM correlation score) from step 2 are then
reported as the final models.
For both the cytoplasmic and periplasmic domains of PrgH, we
applied a 24-mer oligomerization constraint, according to the
established stoichiometry [4,6,11]. For the periplasmic domain, we
observed that in preliminary modelling runs, residues 361–369
moved during the local perturbation step, and led to a model with
a diameter not supported by the EM map, and relatively poor
correlation. No visible density was observed for these residues in
the crystal form reported previously [12], nor in one of the two
molecules in the asymmetric unit of the crystal form reported here,
suggesting that these residues are flexible. We therefore performed
the docking procedures using residues 173–361 (Figure 2), which
led to a model with excellent correlation to the EM map. We note
that residues 370–392 were not resolved in any of the crystal forms
obtained to date, and therefore these residues were not included in
any of the modelling attempts.
The stoichiometry of the T3SS OM secretin has been a matter
of debate, with numbers between 12 and 14 proposed [5,12,13,18]
and recent studies favouring 12 for the secretins of other systems
[19]. Unexpectedly, the recent EM analysis of the SPI-1 basal
body suggested a stoichiometry of 15 [11]. We therefore generated
ring models with stoichiometries of 12, 14 and 15. To reduce the
potential bias of the imposed map averaging, we have carried out
the calculations using both the recent high-resolution EM map
(EMD-1875) [11] and the previous lower resolution 206averaged
map (EMD-1100) [7]. Based on the docking results, the 12-mer
model appears incompatible with the target region of the EM
maps [4], having significantly lower interface energies and worse
map correlation. Using the lower resolution 206 averaged map,
the modelling of the 14- and 15-mer rings results in very similar
interfaces with the 14-mer ring having better correlation to the
EM map and the 15-mer ring having better all-atom energies. Use
of the higher resolution map, however, clearly favours the 15-mer
assembly, with the 14-mer configuration having significantly worse
correlation to the EM map and Rosetta energy. Assuming a fixed-
radius ring, it is expected to have a better-packed interface (and
therefore better full-atom energies) for the more compact 15-mer
ring than for the 14-mer. The 15-mer shows a similar interface
regardless of the map used. Using the high-resolution map, the
modelling converged on two opposite modes – a ‘‘helix in’’
conformation and a ‘‘helix out’’ conformation’’ referring to the
orientation of the helix in the N1 domain of InvG (Figure S1B).
The ‘‘helix in’’ mode shows excellent agreement with our previous
biotinylation [12] and cross-linking [13] experiments, and better fit
with the EM map.
To demonstrate the importance of using experimentally
determined structures for our modelling protocol, we also
generated ring models for the cytoplasmic domain of PrgH and
the periplasmic domain of InvG using homology models based on
Author Summary
Gram-negative bacteria such as E. coli, Salmonella, Shigella,
Pseudomonas aeruginosa, and Yersinia pestis are responsi-
ble for a wide range of diseases, from pneumonia to lethal
diarrhea and plague. A common trait shared by these
bacteria is their capacity to inject toxins directly inside the
cells of infected individuals, thanks to a syringe-shaped
‘‘nano-machine’’ called the Type III Secretion System
injectisome. These toxins lead to modifications of the host
cell, allowing the bacteria to replicate efficiently and/or to
evade the immune system, and are necessary to establish
an infection. As a consequence, the injectisome is an
important potential target for the development of novel
therapeutics against bacterial infection. In this study, we
focus on the basal body, an essential region of the
injectisome that forms the continuous hollow channel
across both membranes of the bacteria. We have used an
array of biophysical methods to obtain an atomic model of
the basal body. This model provides new insights as to
how the basal body assembles at the surface of bacteria,
and could be used for the design of novel antibiotics.
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the previously available structures MxiG [20] and EscC [12]
respectively. For EscC, this strategy led to a model with a similar
interface, but with significantly higher energy. In the case of MxiG
this led to a model with a different interface, which did not
converge during the all-atom refinement step if the PrgH11–120
structure was used in a similar conformation (data not shown), thus
illustrating how the two-step modelling strategy allows for the
discrimination between alternative ring arrangements. For molec-
ular docking applications, the accuracy in the final docking
solution is inherently limited by the precision in the backbone
structure of the monomeric subunits. In the more general case an
accuracy of 2 A˚ backbone RMSD or better in the coordinates of
the monomer is needed to accurately predict the structure of the
docked state [21]. Therefore, the availability of the high-resolution
crystal structures of the monomeric subunits, rather than
homology-based models, combined with the ability to internally
rank models based on EM data, enables for high-resolution
modelling of the symmetric ring complexes (assuming a minimal
degree of change in the conformation of the backbone going from
the monomeric to the complex state) (Figure 3, Figure S2).
To provide support for our modelled interfaces we have
engineered a series of mutant variants and assayed their effect on
secretion in Salmonella cultures. Mutants were designed using
Rosetta to calculate maximal interface disruptiveness and by visual
inspection of the models (Figure 4A). For the cytoplasmic domain
of PrgH, we observed that mutation of two leucine residues to
alanine or an electronegative glutamate (Leu20 and Leu87)
abrogates secretion, while a more conservative mutation to
tyrosine has no effect (Figure 4B, bottom). For the periplasmic
domain of PrgH, we engineered numerous interface and surface
mutations (Figure S3). Notably, we identified a loop (residues 319–
324) that mediates several side- and main-chain contacts with the
adjacent subunit. Side-chain mutations within this loop (K320L,
T324L) have no effect on secretion; however, mutation of the
conformationally labile Gly322 to a leucine abrogates secretion
(Figure 4B, middle), suggesting that the loop main chain
conformation/contacts are more critical to interface integrity.
Finally, for InvG we observed a loop (residues 95–99) forming a
series of side-chain contacts with the adjacent subunit. Mutation of
Gln97 within the loop (which forms a hydrogen bond with the
Figure 1. Structures of individual domains from the Salmonella SPI-1 basal body. (A) Schematic representation of the proteins composing
the basal body. The domain organisation for PrgH (green) and InvG (orange) is shown on the left, and their proposed localization in the EM map of
the injectisome is shown on the right. (B) Ribbon representation of the structures of monomeric InvG22–178, PrgH170–392, and PrgH11–120, with their
localization in the basal body shown. The boundaries of residues that were observable in the density are indicated.
doi:10.1371/journal.ppat.1003307.g001
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adjacent molecule) to leucine – but not alanine - abrogates
secretion (Figure 4B, top). Mutation to alanine of the strictly
conserved Asp95 within the loop (Figure S4) (which lacks any
direct interactions with the neighbouring protomer) has no effect
on secretion. In order to support the hypothesis that the observed
secretion-deficient phenotypes were due to disruption of the
oligomeric interfaces, circular dichroism analysis was used to
ensure the introduction of the mutants did not merely deleteriously
affect the fold of the individual domains (Figure S5). Further, we
purified assembled injectisomes containing mutations in either of
the PrgH or InvG domains. Negative stain EM analysis
demonstrates that despite being necessary for secretion the PrgH
cytoplasmic domain, as observed in a PrgH130–392 mutant (lacking
the N-terminal cytoplasmic domain), is not required for assembly
of the basal body (Figure 4C). However, mutant variant G322Y in
the periplasmic domain of PrgH, or Q97L in InvG, disrupts
needle complex assembly (Figure 4C).
Clearly, a question that arises from our analysis is the lack of
phenotype for several predicted interface mutants, mainly for the
PrgH periplasmic domain (Figure S3). One might argue that the
complexity of the assembled injectisome, where multiple mem-
brane spanning proteins, filaments and accessory proteins, as well
as the membrane environment collectively act to stabilize the basal
body rings, making the ‘‘all or nothing’’ action of a single point
mutant in the context of the assembled T3SS more difficult.
Ideally, the mutant phenotype would be assayed in isolated ring
oligomers from individual domains, where they would be expected
to be more deleterious. However, this is currently unfeasible due to
unsuccessful attempts to reconstitute such T3SS sub-assemblies in
vitro.
From our analysis, each of the three rings shows an excellent fit
to the EM map with correlation coefficients of 0.95, 0.92 and 0.94
for PrgHcytoplasmic, PrgHperiplasmic and InvG models respectively
(Figure 3B, Figure S6 and Video S1). The model of the IM PrgH
periplasmic ring is broadly similar to previously reported models
from our groups and others [11,13]. The corresponding region of
the EM map is rich in detail and the availability of our previously
published crystal structure of this domain facilitated the accurate
positioning in the map (Figure S6) and reconstruction of the
oligomer [11]. Nonetheless, the average backbone RMSD
between the presented model and those previously deposited
(PDB ID 2Y9J) is 2.9 A˚, corresponding to a small rotation of the
monomer subunits (Figure S7). Importantly, our PrgH periplasmic
domain model possesses fully refined interfaces (Figure S2B).
For the cytoplasmic domain, the structure of the orthologues
from Chlamydia (CdsD) (PDB ID: 3GQS), Shigella (MxiG) [20,22]
and Yersina (YscD) [23,24] recently confirmed predicted homology
to the family of forkhead associated (FHA) domains (Figure S8).
Tentative ring models were proposed for MxiG [20,22]; however,
comparison to the model presented here is not possible in the
Figure 2. Illustration of the 2-step ring structure modelling approach for the PrgH periplasmic domain. (A) In the first step, fixed-
backbone symmetric docking was performed starting from the structure of the monomer. The resulting two clusters of ring arrangements cl1 and cl2
differ in the orientation of the C-terminal domain (B). More sampling was then performed, focusing in the vicinity of the two candidate structures,
using perturbation symmetric docking runs (see methods) (C). At this step, the backbone is allowed to move to allow for more efficient energy
discrimination. While Cluster 2 quickly diverges from the starting-point seed structure (C-cl2), Cluster 1 runs sink into a lower-energy funnel (C-cl1)
(starting structures for the perturbation runs are indicated with vertical dashed lines). The final, low-energy ensemble (indicated below the horizontal
dashed line in (B-cl1)) shows highly converged features in terms of the backbone conformation and side-chain packing along the interface (D). Only
two adjacent subunits of the 24mer complex are shown for simplicity. The RMSDs are computed for backbone atoms of the entire modelled 24mer
complex in (A), while in (C) RMSD values are reported for a single dimeric interface relative to the lowest-energy sampled model. The EM map EMD-
1875 is used to restrain both steps of docking calculations, although in the last flexible-backbone stage the weights are reduced to one-half relative
to the first, rigid-backbone step.
doi:10.1371/journal.ppat.1003307.g002
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absence of available coordinates for the Shigella variant (although
from the published figures the models appear to be generally
oriented in a similar fashion). FHA domains are frequently
involved in interaction with phosphothreonine (pThr)-modified
proteins. In Shigella, the PrgH orthologue MxiG was reported to
interact with phosphorylated peptides from the secretion appara-
tus protein Spa33 [20] although a separate study failed to
corroborate these results [20,22], and structures of the Yersinia
orthologue YscD revealed an unconserved phosphothreonine
binding motif [23,24]. Protein sequence alignment of the PrgH
orthologues indeed illustrates that the conserved residues involved
in phosphopeptide binding in FHA domains are poorly conserved
(Figure S9). To validate this, we engineered mutations of the PrgH
residues corresponding to the proposed phosphothreonine inter-
acting residues in MxiG - Arg35, Gln42 and Asp65 - to alanine.
These mutations have no effect on in vivo secretion assays (Figure
S10). We therefore conclude that the PrgH cytoplasmic domain is
unlikely to interact with pThr-modified proteins. We note however
that the FHA phosphopeptide interacting loops in our PrgH
structure are accessible on the cytoplasmic face of the ring model,
suggesting a potential interface for protein-protein interactions.
Indeed, deletion of this domain results in the formation of
secretion incompetent immature basal body assemblies lacking
needles (Figure 4C) suggesting a role in the correct assembly/
coordination of the inner-membrane export apparatus.
For the InvG periplasmic domain, our newly generated ring
model is significantly different from existing ones [11,12], with an
average backbone RMSD of over 5.5 A˚ between our model and
the previously deposited one (PDB ID 2Y9K) (Figure S2A and
S7)). Importantly, the fully refined interface in our model does not
present the atomic clashes present in the previous model. This
model was based on homology modelling from the distant EPEC
orthologue EscC (22% sequence identity between the periplasmic
domains, Figure S4). Superposition of the InvG and EscC crystal
structures revealed a similar organization, with the N0 and N1
domains common to the secretin family [19,25]; however, the
relative orientation of these domains is shifted 36 degrees between
the two proteins (Figure S11).
Collectively therefore, the basal body model reported here
marks a significant advancement from prior models. Of note, the
modelling protocol clearly favoured a 15-mer stoichiometry for
InvG, in support of recent EM analysis [11]. This result is however
in contradiction with the stoichiometry of other secretin proteins
[5,19,26,27,28], and further studies will be required to confirm if
this represents a true system-to-system variation.
Discussion
We have previously observed the presence of a common
modular domain, which we termed ring-building motif (RBM), in
all the proteins comprising the basal body as well as components of
the IM export apparatus [12,29,30]. Structural comparison of the
intra-subunit interactions of the RBMs in the basal body model
supports our previous hypothesis that this domain functions as an
oligomerization scaffold, with a conserved interaction mechanism
in three RBM mediated interfaces of PrgH and InvG. In all three
cases, the conserved interface consists of the N-terminal helix
packing against the three-stranded beta sheet of the motif
(Figure 5A). Analysis of the electrostatic profile at the RBM
interface suggests the driving force for self-association is the
complementary charge between the surface formed by the three-
stranded beta-sheet and the surface formed by the two helices
(Figure 5B). Importantly, similar interactions are present in the
oligomeric structure of the EPEC basal body component EscJ [6],
suggesting that the RBM plays a common species-independent
role in the assembly of the three basal body components. Further,
the subsequent observation of an RBM in the T2SS secretin
[25,31] and the intercellular channel complex in sporulating
Bacillus subtilis [32,33] suggests this mechanism is likely applicable
to related bacterial systems. It should be noted that the N-terminal
RBMs of PrgH (defined in the new crystal form of PrgH170–392
reported here) and EscJ do not form the conserved oligomerization
Figure 3. Models of the PrgH and InvG rings. (A) Ribbon representation of the lowest-energy models obtained for PrgH cytoplasmic domain
(bottom, dark green), PrgH periplasmic domain (centre, light green) and InvG periplasmic domain (top, orange). (B) Fit of the PrgH (green) and InvG
(orange) ring models in the SPI-1 T3SS EM map (EMD-1875) [11]. A close view for the fit of each individual subunit in the EM map density is shown on
the right, illustrating the good fit of each subunit within the density.
doi:10.1371/journal.ppat.1003307.g003
Structure of the Salmonella T3SS Basal Body
PLOS Pathogens | www.plospathogens.org 6 April 2013 | Volume 9 | Issue 4 | e1003307
interface and appear involved in intra-domain interactions or
membrane association.
All the reported purified domains of the T3SS basal body are
monomeric in solution, showing that the membrane-embedded
domains and/or the presence of additional proteins are necessary
for their oligomerization. Nonetheless, in our earlier structures of
the IM protein EscJ from EPEC we observed a 24mer oligomeric
packing generated around the 6 fold screw axis of the crystals, the
first direct insight into the oligomerization number and interfaces
of the ring which has subsequently been supported in re-evaluation
of higher resolution EM analysis [11] and has been the basis for all
subsequent models of that component and orthologues in the
literature. Prompted by this, we investigated if the crystal packing
in the structures reported here could be correlated to the interfaces
found in our oligomeric models. We observed that the cytoplasmic
domain of the second basal body IM ring, PrgH11–120, forms a
hexamer in the asymmetric unit of the crystal (Figure S12A), with
the two interfaces involved in generation of the hexamer being the
most sequence conserved surface region (Figure S12B). Compar-
ison of our subsequent Rosetta-EM generated PrgH11–120 24-mer
and hexameric crystal packing reveals that the surfaces used for
protein-protein contacts is the same in the 6-mer of the crystal
form and in the 24-mer of the oligomeric model (Figure 6A). A
,20u subunit rotation in the hexamer of the crystal structure
accommodates the tighter packing but superposition of the
interface secondary structural units shows significant conservation
with both interfaces having similar buried surface areas (640 A˚2 vs.
546 A˚2 for hexamer and 24mer respectively). For the periplasmic
PrgH170–392 domain, crystallographic symmetry-related molecules
in the crystal produce a dimer that exploits the same general
interface as the 24-mer biological assembly (Figure 6B). Similarly,
a dimer formed by a unit cell translation from the InvG crystal
lattice superposes with a dimer from the modelled 15-mer ring
(Figure 6C). Collectively, the crystallographic packing interfaces
Figure 4. Experimental validation of the ring models. (A) The interface between two subunits for each of the three models is shown. Selected
residues involved in contacts are highlighted, which were mutated for secretion assays. (B) Coomassie-stained SDS-page gel of proteins secreted by S.
Typhimurium strains with a chromosomal deletion of the genes coding for PrgH or InvG, complemented with plasmids containing the corresponding
genes, or mutants. The flagellin protein FliC is used as a loading control. The effector protein SipA is secreted when the bacteria express wild-type
proteins, but mutation of Gln 97 to leucine in InvG, Gly 322 to tyrosine in PrgH periplasmic domain, or both Leu 20 and Leu 87 to alanine in PrgH
cytoplasmic domain show impaired secretion. (C) Electron micrographs of purified T3SS injectisome particles for various InvG or PrgH mutants.
Deletion of the cytoplasmic domain of PrgH leads to the formation of injectisome particles that lack the needle (bottom panel, red arrows). Mutation
of Gly 322 to tyrosine in the PrgH periplasmic domain (middle panel) leads to the observation of a mix of assembled basal body (red arrow) and
individual rings which could consist of either the inner- or outer-membrane components (blue arrows). Finally, mutation of Gln 97 to leucine in InvG
severely disrupts the assembly of the T3SS, with only few single rings visible (top panel, red arrows). The white bar indicates 100 nm.
doi:10.1371/journal.ppat.1003307.g004
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we observe support and mirror the low energy interfaces generated
in our modelled basal body. This would be consistent with a model
whereby the soluble domains have low-affinity interaction surfaces
for oligomerization, which can be captured by the high
concentration in the crystallization experiment. In vivo, oligomer-
ization is likely dependent on membrane localization and
potentially nucleation by additional members of the injectisome.
Finally, analysis of the surface electrostatics of the InvG and
PrgH periplasmic ring models reveals an acidic surface present on
the face of the InvG ring proximal to PrgH, and a complementary
basic surface on the corresponding face of PrgH (Figure 5C). This
charge complementarity may provide an initial force of attraction
in the assembly of the inner and outer membrane components of
the basal body. Furthermore, we observed a positively charged
Figure 5. Molecular basis for the SPI-1 basal body assembly. (A) Overlaid view of the interface formed by the RBMs of adjacent molecules for
InvG (orange) and PrgH (green for domain 1, blue for domain 2) in the ring models. In all three cases, the orientation of the domains is similar, with
the two helices stacking against the three-stranded sheet. (B) Electrostatic surface representation of individual subunits from the PrgHperiplasmic
(bottom) and InvG (top) ring models. The charged surfaces forming the basis of the interaction between RBMs are indicated in grey boxes. (C)
Electrostatic surface representation of the InvG ring model (top) and PrgH periplasmic domain ring model (bottom). The negative charge at the
bottom of the InvG ring, as well as the positive charge on the top of the PrgH ring, is shown, suggesting a charge-driven mechanism for the assembly
of the Salmonella SPI-1 T3SS basal body. The positively charged interior of the InvG N0 ring is also visible.
doi:10.1371/journal.ppat.1003307.g005
Figure 6. Crystal contacts reflect the oligomerization interface. Overlay of the crystal contacts (grey structures) and the oligomeric interface
in the reported ring models, for the cytoplasmic domain of PrgH (A), periplasmic domain of PrgH (B) and periplasmic domain of InvG (C). In all three
cases, the crystallographic contacts are formed with an interface that is similar to the interface in the ring model, although the curvature imposed by
the oligomeric state differs, leading to some differences in specific side-chain interactions.
doi:10.1371/journal.ppat.1003307.g006
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interior collar of the InvG ring corresponding to the N0 domain
(Figure 5C), where residues are proposed to be in contact with the
inner rod and socket [11,34]. This surface is formed by a set of
basic residues lying on one side of the InvG monomer (Figure
S13). In particular, we have previously shown that mutation of
Lys67 abrogates secretion by altering substrate switching [13].
From these observations, we can propose a model whereby a large
number of weak, charge-based interactions between individual
subunits of the basal body lead to a stable complex upon assembly.
This is most likely the reason why all the purified soluble domains
do not oligomerize in vitro, in the absence of the stabilizing trans-
membrane domains and lipidic membrane environment. Similar
multivalent interactions probably govern the interaction between
the basal body and other components of the injectisome, namely
the rod and needle. This model is in agreement with the
observation that extreme pH conditions lead to the disassembly
of the injectisome [7,11].
While the agreement with the experimental data is compelling,
it should be recognized that we have provided models of the ring
assemblies, not experimentally determined high resolution struc-
tures. In particular, we assume in the initial docking calculations
that there are no large scale conformational changes between the
monomeric and oligomeric states of individual domains, and that
all subunits are identical in the assembled basal body. Further-
more, since the monomers do not spontaneously oligomerize, it is
possible that other components, such as the membrane scaffolding,
influence the conformation of the oligomeric assembly.
In summary, we report the crystal structures for the cytoplasmic
and periplasmic domains of PrgH and InvG, two of the main basal
body components of the prototypical Salmonella SPI-1 injectisome.
We have refined these structures into the EM density using
Rosetta symmetric flexible backbone docking calculations, gener-
ating ring models for these domains that exhibit a high degree of
correlation to the Salmonella SPI-1 basal body EM map. The
modelling procedure produced converged, low-energy interfaces,
which were validated by in vivo functional assays. The obtained
models provide insights into the discrete interactions occurring
during assembly of the T3SS basal body. Analysis of the packing of
the previously identified modular domain common to the three
basal body components confirms that it represents a common ring-
building motif with an electrostatically-driven oligomerization
mechanism likely conserved amongst the many clinically impor-
tant bacteria that rely on a T3SS for their pathogenic effects.
Materials and Methods
Cloning, protein expression and purification
The gene coding for PrgH11–120 was amplified by PCR from
Salmonella enterica serovar Typhimurium genomic DNA and cloned
into the pET-28(a) plasmid (Novagen) fused to a 6xHis tag at the
N-terminus followed by a thrombin cleavage site, using restriction-
free PCR [35]. The obtained pET-PrgH11–120 was transformed
into BL21(DE3) competent cells, and kanamycin-resistant colonies
were used to inoculate LB media containing 50 mg/ml of
kanamycin, at 37uC to an OD600 of ,0.5. Expression was
induced by IPTG at 0.1 mM, and the protein was expressed at
20uC for 20 hours. Cells were harvested, resuspended in buffer
(50 mM TRIS pH 7.4, 300 mM NaCl, 20 mM imidazole), lysed
by sonication and debris pelleted at 45,000 g for 50 min. The
protein was purified from the supernatant by passing it through
Ni-activated chelating sepharose, and the His-tag was subsequent-
ly removed by adding thrombin (Roche) at 1:1000 dilution for
16 hours at 4uC. The protein was further purified by size-
exclusion chromatography using a Superdex75 gel filtration
column (GE Healthcare). Expression and purification of
PrgH170–392 was performed as described previously [12].
The gene coding for InvG22–178 was amplified by PCR from S.
Typhimurium genomic DNA and cloned into the pET-28(a)
plasmid (Novagen) fused to a 6xHis tag at the N-terminus followed
by a thrombin cleavage site, using restriction-free PCR[35]. The
obtained pET-InvG22–178 was transformed into BL21(DE3)
competent cells, and kanamycin-resistant colonies were used to
inoculate LB media containing 50 mg/ml of kanamycin, at 37uC
to an OD600 of,0.5. Expression was induced by IPTG at 1 mM,
and the protein was expressed at 37uC for 5 hours. Cells were
harvested, resuspended in buffer (50 mM HEPES pH 6.8,
150 mM NaCl), lysed by sonication and debris pelleted at
45,000 g for 50 min. The protein was purified from the
supernatant by passing it through Ni-activated chelating sephar-
ose, and the His-tag was subsequently removed by adding
thrombin (Roche) at 1:1000 dilution for 16 hours at 4uC. The
protein was further purified by size-exclusion chromatography
using a Superdex75 gel filtration column (GE Healthcare).
For SeMet-labelled protein, bacteria were grown in minimal
media containing 100 mgs each of added L- Lysine, Phenylala-
nine, and Tyrosine; 50 mgs of L- Isoleucine, leucine, and valine;
and 60 mgs selenomethionine per litre. Purification was per-
formed as for unlabelled protein.
Crystallization
All initial crystallization trials were performed by sitting-drop
vapour diffusion using a Phoenix drop setter (Rigaku). Crystals of
PrgH11–120 (5–10 mg/ml) were grown at 20uC by sitting-drop
vapour diffusion using 15–20% PEG 6000, 0.02 M CaCl2, 0.1 M
HEPES pH 6.5 as reservoir solution. Crystals of PrgH170–392 were
obtained at 20uC in a range of conditions using protein samples at
2 mg/ml concentration or less, and all requiring the presence of
PEG precipitants. The crystals were all of a new crystal form
(compared to those previously-reported by our group [12]), and
optimal diffraction was obtained for crystals grown in 100 mM
bicine pH 8.5, 20% PEG 6000.
InvG22–178 crystallized in several conditions at 20uC, with pH
above 7.5 and containing PEG precipitating agents, but formed
clusters of needles not amenable for data collection. Single crystals
could be obtained by decreasing the protein concentration to
approximately 4 mg/ml, and the best diffraction was obtained for
crystals grown in 100 mM HEPES pH 8.0, 30% jeffamine M-600.
Selenomethionine-labelled protein crystallized similarly.
Data collection and structure refinement
Crystals were cryo-protected by soaking in the crystallization
condition supplemented with 30% glycerol and flash-cooled in
liquid nitrogen. Data were collected at beamline 8.1 of the
Advanced Light Source (ALS) and beamline CMCF-1 of the
Canadian Light Source (CLS) at 100 K. For PrgH11–120, a
mercury chloride derivative was obtained by soaking in cryo-
protectant +2 mM mercury chloride for 10 minutes. A three
wavelength MAD experiment was subsequently carried out as well
as collection of a high-resolution native dataset in the absence of
mercury chloride. For InvG22–178 a three wavelength MAD
experiment on selenomethionine-derivative crystals was carried
out, and a native dataset was collected.
Data were processed and scaled with HKL2000 [36] and
MOSFLM [37]/SCALA [38]. For PrgH170–392, a molecular
replacement solution was found with the program PHASER [39]
using the PDB file 3GR0 as a search model, and an initial model
was built using ARP/WARP [40]. For PrgH11–120 and InvG22–178,
structure determination and initial model building were carried
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out with the PHENIX suite [41], which identified 12 Hg atoms for
PrgH11–120 (FOM 0.51) and 6 Selenium sites for InvG22–178 (FOM
0.54). All models were further refined with REFMAC5 [42] and
PHENIX, using TLS parameters [43]. Data processing and model
refinement statistics are summarized in Table 1. Structure quality
was assessed with PHENIX and all models have good stereo-
chemistry with PrgH11–120, PrgH170–392 and InvG22–178 having
respectively 96.46%, 98.1% and 97.9% of residues in the favoured
region of the Ramachandran plot with no outliers. We note the
presence of four PEG molecules and four phosphate ions per
asymmetric unit in the PrgH170–392 crystal structure, for a total of
76 ion/ligand atoms. These molecules were present in the
crystallization condition or cryoprotectant buffer, and are there-
fore not likely to be biologically relevant. The coordinates for
PrgH11–120, PrgH170–392 and InvG22–178 have been deposited to
the PDB, under the accession numbers 4G2S, 4G08 and 4G1I
respectively.
Ring modelling
Rosetta modelling made use of standard symmetric docking
protocols [14,44] augmented with a term assessing agreement to
experimental cryo-EM density [15]. For all symmetric assemblies
considered here, symmetric docking calculations were performed
in two steps: in a first step, fixed-backbone docking calculations
were performed using the monomer conformations from the
crystal structures in a randomized orientation. This procedure
typically resulted in the identification of a small number of local
minima, suggesting potential binding modes for each assembly. In
the second, refinement step, we performed a fine-grained local
search starting from each binding mode identified in step (1).
Here, the rigid body degrees of freedom underwent small random
perturbations in a number of Monte-Carlo trajectories. Finally, for
each trajectory we performed gradient-based optimization of all
backbone, side-chain and rigid body degrees of freedom. The
command lines used for each procedure are deposited in Appendix
S1. The coordinates for the PrgHcytoplasmic, PrgHperiplasmic and
InvG ring models have been deposited to the PDB, under the
accession numbers 3J1W, 3J1X and 3J1V respectively.
Secretion assay
For complementation assays, mutants were engineered into a
plasmid containing the genes coding for PrgH or InvG, described
previously [13,45], using the QuickChange mutagenesis kit
(QIAGEN). The obtained plasmids were transformed into
electro-competent PrgH- or InvG-deletion strains of S. Typhimur-
ium. Secretion assays were performed as described previously
[13,45]. Briefly, 5 ml LB cultures of S. Typhimurium strains were
grown at 37uC overnight, and cells were then pelleted at 6,000 g
for 10 min. Proteins in the supernatant were precipitated by
adding 10% TCA and pelleted at 6,000 g for 30 min. Pellets were
washed in 0.5 ml acetone, re-suspended in 20 ml gel loading
buffer, boiled, and ran in a 10% acrylamide SDS-PAGE gel that
was stained with Coomassie Blue.
Injectisome purification and electron microscopy analysis
Electro-competent strains of S. Typhimurium lacking the gene
for FliC and either InvG or PrgH [45] were transformed with a
plasmid containing the genes coding for PrgH or InvG, described
above, or the corresponding mutants. These transformants were
used to make electro-competent cells, which were transformed
with a plasmid containing the gene coding for the T3SS
transcription activator HilA. The obtained transformants were
then used for purification of the injectisome, as described
previously [45].
For EM analysis, purified injectisome samples were diluted in
10 mM Tris pH 8.0, 500 mM NaCl, 5 mM EDTA and 10 mM
LDAO. They were prepared on carbon grids and stained with
0.75% uranyl formate using standard procedures. Images were
collected with a H7600 Transmission Electron Microscope
(Hitachi Hi-Technologies Canada, Inc.) equipped with a side
mount AMT Advantage (1 mega-pixel) CCD camera (Hamamatsu
ORCA), and operated at an acceleration voltage of 120 kV.
Circular dichrosim
Circular dichroism (CD) spectra were recorded with a nitrogen-
flushed Jasco J-810 spectro-polarimeter, at 20uC. Proteins were
dialyzed against buffer containing 5 mM Tris pH 8 and 50 mM
NaCl prior to analysis. 0.1–0.5 mg/ml protein was used with a
path length of 0.1 cm. Data were recorded from 260 to 190 nm
using a 2 s time constant, 10 nm min21 scan speed and a spectral
bandwidth of 1 nm. Spectra were corrected for buffer.
Structure analysis and representation
The multiple sequence alignments (Figures S4 and S9) were
made with ClustalW [46] and the figures generated with ESPript
[47]. RMS distances were calculated with PyMol (Schrodinger,
LCC). Electrostatic surfaces were calculated with the APBS
module [48] in PyMol. Domain angle differences were measured
with HingeFind [49]. Conserved residues were mapped on the
structures with ConSurf [50]. Map fitting was performed with
Chimera [51]. All structure figures were generated with Pymol or
Chimera.
Supporting Information
Figure S1 Illustration of the 2-step ring structure
modelling approach for the PrgH cytoplasmic domain
and InvG periplasmic domain. The results of the fixed-
backbone symmetric docking stage and for the perturbation
docking calculation are shown for the PrgH cytoplasmic domain
(A) and InvG periplasmic domain (B); RMSDs are computed for
backbone atoms of the entire modelled 24mer complex for the
fixed-backbone docking, while RMSD values are reported for a
dimeric interface relative to the lowest-energy sampled model for
the perturbation docking calculation. The EM map is used to
restrain both steps of docking calculations, although in the last
flexible-backbone stage the weights are reduced to one-half
relative to the first, rigid-backbone step. (A) Two clusters of
arrangements are identified in the fixed-backbone docking stage
differing in the orientation of the C-terminus: in cluster 2, the
orientation of the monomeric subunit is ‘‘flipped’’ relative to the
center of the ring. Cluster 2 is a more collapsed ring that was
excluded from further consideration on the basis of its poor fit to
the EM map. Cluster 1 was then used as a seed for perturbation
docking calculations in which the backbone degrees of freedom are
also optimized to allow for more efficient energy discrimination.
The final, low-energy ensemble (indicated below the horizontal
dashed line) shows highly converged features in terms of the
backbone conformation and side-chain packing along the
interface. (B) Two clusters of arrangements are identified in the
fixed-backbone docking stage differing in the orientation of the C-
terminal domain: in cluster 2, the orientation of the monomeric
subunit is ‘‘flipped’’ relative to the center of the ring. Cluster 2 was
excluded from further consideration based on biochemical data
(see the text). In the flexible-backbone step starting from cluster 1
(vertical dashed line), we obtain a highly converged low-energy
interface (indicated below the horizontal dashed line).
(TIF)
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Figure S2 The well-packed interface of the PrgH and
InvG ring models. The ring models of InvG periplasmic
domain (A, orange), PrgH periplasmic domain (B, green) and
PrgH cytoplasmic domain (C) are shown on the left, overlaid on
the models reported previously (in blue and purple, for (A) and (B)
respectively). A close-up of the interface between molecules is
shown on the right, with the interface side-chains apparent. For all
three models, the interfaces are well packed, with a relevant
network of interactions.
(TIF)
Figure S3 Mutants generated for the PrgH periplasmic
domain. The location of all the mutated residues that were tested
for secretion assay (K218A, K218L, E227L, D251A, D251L,
I234A, I234L, Y239A, R231Y, I234R, Y238F, R262A, R262L,
Q263A, Q263L, D295A, D295L, V297R, K308L, Q309Y,
K320L, G322Y, T324H, K218A/D251A, K218A/Y239A,
K218L/Y239A, K218L/Y239F, Y239A/E252A) is indicated on
a PrgH molecule shown in cartoon representation, with the
adjacent molecules in the ring model shown in surface represen-
tation. Only the G322Y mutant abrogated secretion (see Figure 4B)
(TIF)
Figure S4 Multiple alignment of the sequences from the
secretins of several T3SSs. InvG_SPI1: S. Typhimurium SPI-
1 secretin InvG; EivG_ETT2: Enterohaemorrhagic E. coli ETT2
secretin EivG; MxiD_Shi: Shigella secretin MxiD; YscC_Yer:
Yersinia pestis secretin YscC; PscC_Pse: Pseudomonas aeruginosa
secretin PscC; EscC_LEE: Enteropathogenic E. coli LEE secretin
EscC; SsaC_SPI2: S. Typhimurium SPI-2 secretin SsaC. Strictly
conserved residues are in a red box, similar residues are in red
characters. The secondary structures for the periplasmic domains
of InvG and EscC are in blue (top) and green (bottom)
respectively.
(TIF)
Figure S5 Circular dichroism analysis of InvG22–178,
PrgH170–392 and PrgH11–120. Circular dichroism (CD) spectra
of the crystallized domains of InvG and PrgH demonstrate the
designed interface destabilizing mutants PrgH11–120 L87A (A),
PrgH170–392 G322L (B) and InvG22–178 Q97L (C) have minimal
effect on the overall secondary structure. CD is reported in mdeg
and overlaid spectra have been corrected for protein concentra-
tion.
(TIF)
Figure S6 Fit of the ring models into the EM map. Close
view of a monomer from the InvG (top), PrgHperiplasmic (middle)
and PrgHcytoplasmic (bottom) ring models, into the EM map density
(EMD-1875). Side views (left) and top views (right) are shown, and
a lower contour level (0.075 for InvG, 0.08 for PegHperiplasmic and
0.045 for PrgHcytoplasmic) compared to figure 3B is used for the EM
density, for closer illustration of the fit quality.
(TIF)
Figure S7 Comparison with previous models. The
RMSD between monomers in our PrgHperiplasmic and InvG
models (green and orange respectively) and the models reported by
Schraidt and Marlovits (grey) were calculated using PyMol. The
difference in atom position is shown in yellow bars, illustrating the
rotation in the PrgH model and the dramatic difference in the
InvG model.
(TIF)
Figure S8 Comparison of the C-terminal domain or
PrgH with its orthologues. Ribbon representation of PrgH11–
120 (green), overlaid with the structures of its orthologues MxiG
(pdb:2XXS, orange) from Shigella, and CT664/CdsD (pdb: 3GQS,
blue) from Chlamydia, viewed from the side of the beta-sandwich
(left) and from the top (right). The common FHA fold is illustrated,
with the variable single helix clearly apparent.
(TIF)
Figure S9 Multiple alignment of the sequences from
PrgH orthologues in several T3SSs. PrgH_SPI1: S.
Typhimurium SPI-1 protein PrgH; EprH_ETT2: Enterohae-
morrhagic E. coli ETT2 protein EprH; MxiG_Shi: Shigella
protein MxiG; YscD_Yer: Yersinia pestis protein YscD;
PscD_Pse: Pseudomonas aeruginosa protein PscD; EscD_LEE:
Enteropathogenic E.coli LEE protein EscD; SsaD_SPI2: S.
Typhimurium SPI-2 protein SsaD. Strictly conserved residues
are in a red box, similar residues are in red characters. The
secondary structure of the cytoplasmic and periplasmic domains
of PrgH is shown at the top (blue), and of the periplasmic
domain of MxiG at the bottom (green). Red stars indicate
proposed phThr-binding residues.
(TIF)
Figure S10 The putative pThr-binding residues of PrgH
are not necessary for secretion. Coomassie-stained SDS-
page gel of proteins secreted by S. Typhimurium strains with a
chromosomal deletion of PrgH, complemented with a plasmid
containing the PrgH gene or mutants. The flagellin protein FliC is
used as a loading control. Secretion is not affected by the R35A,
Q42A or D65A mutations, demonstrating that these residues are
not essential for function.
(TIF)
Figure S11 Structural differences between InvG and
EscC. Ribbon representation of the structure of InvG22–178
(orange), overlaid onto the structure of EscC21–174 (cyan). The
overlay was based on the N1 domains, illustrating the shift in
relative orientation for the N0 domain, viewed from the side (left)
or front (right).
(TIF)
Figure S12 PrgH11–120 crystallizes as a hexamer. Ribbon
representation of the PrgH11–120 crystal asymmetric unit. (A) The
six molecules form a ring, with the helix located in the lumen. (B)
Residue conservation is indicated on the surface representation,
with the most conserved residues shown in red and the least
conserved residues in blue. Conserved residues are primarily
located at the interface between molecules, suggesting that this
interface is biologically relevant.
(TIF)
Figure S13 Molecular basis for the charge repartition in
the InvG ring model. Ribbon representation of the InvG22–178
monomer, with the residues forming the basic lumen of the InvG
ring shown in blue, and those forming the acidic patch at the
bottom of the InvG ring shown in red.
(TIF)
Appendix S1 Detailed protocol for the two-step model-
ling procedure. (A) Schematic representation of the procedure
employed. (B) Command lines used in Rosetta for the modelling
procedure.
(DOC)
Video S1 Ring models of the PrgH cytoplasmic domain (dark
green), PrgH periplasmic domain (green) and InvG periplasmic
domain (orange) docked in the EM map of the injectisome (EMD-
1875, grey).
(MOV)
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